PT  - JOURNAL ARTICLE
AU  - Kollepara, Pratyush K.
AU  - Chisholm, Rebecca H.
AU  - Miller, Joel C.
TI  - Heterogeneity in network structure switches the dominant transmission mode of infectious diseases
AID  - 10.1101/2022.11.28.22282692
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.11.28.22282692
4099  - http://medrxiv.org/content/early/2022/11/29/2022.11.28.22282692.short
4100  - http://medrxiv.org/content/early/2022/11/29/2022.11.28.22282692.full
AB  - Several recent emerging diseases have exhibited both sexual and non-sexual transmission modes (Ebola, Zika and mpox). In the recent mpox outbreaks, transmission through sexual contacts appears to be the dominant mode of transmission. Motivated by this, we use an SIR-like model, to argue that an initially dominant sexual transmission mode can be overtaken by casual transmission at later stages, even if the basic casual reproduction number is less than one. Our results highlight the risk of intervention designs which are informed only by the early dynamics of the disease.Significance Statement The purpose of this article is to explore the risk from secondary transmission routes of diseases which spread through sexual contact. This is important because infectious diseases such as Ebola, Zika and mpox spread through both sexual transmission and other modes of transmission. Our results suggest that a secondary transmission route which is not dominant in the initial stages, can significantly alter the course of the epidemic and lead to more infections than expected in the later stages of the epidemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by startup funds (including a PhD scholarship to PKK) provided to JCM from La Trobe University.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript. Simulation software for this modeling study are available at https://github.com/Joel-Miller-Lab/casual-sexual-transmission. Finalized versions of all software will be available on an external repository following final acceptance. https://github.com/Joel-Miller-Lab/casual-sexual-transmission